Literature DB >> 9229883

[Prolonged sick-leave: the role of general practitioner].

J Lous1, M Nord-Larsen, F Olesen.   

Abstract

The aim was to study why long sick leave benefit cases had taken a long time with special focus on the communication between the general practitioner and the social service department. An explorative study was made of the development and communication in 27 consecutive lengthy sick leave cases that had lasted more than 13 weeks, that were discussed at three audit panels with participation of the social worker/officer in charge, the general practitioner and the representatives from the local hospital. The study took place in Aarhus County in 1994. The results were that many of the same problems were found in various cases, such as insufficient certificates, inappropriate use of benefit certificates, waiting times for examinations, treatment and especially rehabilitation. In the more complicated cases, of which there were many, a coordinating person would have helped matters. The GP's were willing to take on this role. The main reasons for lengthy benefit cases were that the illness was medically complicated and of a long duration.

Entities:  

Mesh:

Year:  1997        PMID: 9229883

Source DB:  PubMed          Journal:  Ugeskr Laeger        ISSN: 0041-5782


  3 in total

1.  Frequency and nature of problems associated with sickness certification tasks: a cross-sectional questionnaire study of 5455 physicians.

Authors:  Anna Löfgren; Jan Hagberg; Britt Arrelöv; Sari Ponzer; Kristina Alexanderson
Journal:  Scand J Prim Health Care       Date:  2007-09       Impact factor: 2.581

2.  Problems in sickness certification of patients: a qualitative study on views of 26 physicians in Sweden.

Authors:  Mia von Knorring; Linda Sundberg; Anna Löfgren; Kristina Alexanderson
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

3.  How primary health care physicians make sick listing decisions: the impact of medical factors and functioning.

Authors:  Gunilla Norrmén; Kurt Svärdsudd; Dan K G Andersson
Journal:  BMC Fam Pract       Date:  2008-01-21       Impact factor: 2.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.